Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Wilmington Healthcare appoints new Account Director

September 26, 2017 | Wilmington 

Healthcare intelligence provider Wilmington Healthcare, which incorporates Binley’s, NHiS, Wellards and HSJ, has strengthened its salesforce with the appointment of Gareth Thurston as Account Director.

In his new post, Gareth will be overseeing a number of key accounts across the Wilmington Healthcare portfolio and ensuring that the relevant specialist teams meet their objectives.

Gareth who has worked in sales and marketing roles in the healthcare industry for nearly 30 years, joins Wilmington Healthcare from Cello Health Consulting Ltd, where he was a consultant.

Prior to that, Gareth spent nearly 10 years at Novartis Pharmaceuticals UK Limited, where he held a number of different roles, including Marketing Manager and Franchise Lead for the company’s transplantation portfolio. His final post at the company was Brand Lead, Ophthalmology.   Before joining Novartis, Gareth held senior sales and product manager positions at Gilead Sciences Ltd in their anti-infective franchise.

Gareth Thomas, Managing Director of Wilmington Healthcare, said: “Having worked in sales and marketing roles in the healthcare industry for nearly 30 years, Gareth Thurston brings a wealth of experience to his new job.

“He will play an important role in supporting our clients to achieve greater success, whilst helping our business to continue to go from strength to strength. We are very pleased to welcome him to our team.” 

- PMLiVE
Gareth Thurston

This content was provided by Wilmington Healthcare

Company Details

Wilmington Healthcare

Wilmington Healthcare

Email
Website

 Latest Content from  Wilmington Healthcare 

Hear from her: Women's Health Faces Some Difficult Headwinds. Here's How We Can Move Forward

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...